Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

4 Issues per year

CiteScore 2016: 1.43

SCImago Journal Rank (SJR) 2016: 0.375
Source Normalized Impact per Paper (SNIP) 2016: 0.901

Open Access
See all formats and pricing
More options …
Volume 4, Issue 1 (Mar 2011)


Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress

Katarína Bauerová
  • Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Silvester Poništ
  • Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Danica Mihalová
  • Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ František Dráfi
  • Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Viera Kuncírová
  • Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-04-18 | DOI: https://doi.org/10.2478/v10102-011-0007-9

Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress

As a number of disease-modifying anti-rheumatic drugs often have side effects at high doses and/or during long-term administration, increased efficacy without increased toxicity is expected for combination therapy of rheumatoid arthritis (RA). The safety of longterm therapy of RA is very important as patients with RA are usually treated for two or more decades. This experimental overview is focused on some promising substances and their combinations with the standard antirheumatic drug - methotrexate (Mtx) for treatment of rheumatoid arthritis. The adjuvant arthritis model in Lewis rats was used for evaluation of antiinflammatory efficacy of the substances evaluated. Mtx was administered in the oral dose of 0.3 mg/kg b.w. twice a week. Natural and synthetic antioxidants were administered in the daily oral dose of 20 mg/kg b.w for coenzyme Q10 (CoQ10), 150 mg/kg b.w for carnosine (Carn), 15 mg/kg b.w. for stobadine dipalmitate (Stb) and its derivative SMe1.2HCl (SMe1), and 30 mg/kg b.w. for pinosylvin (Pin) or pterostilbene (Pte). Mtx in the oral dose of 0.4 mg/kg b.w. twice a week was combined with Pin in the oral daily dose of 50 mg/kg b.w. Clinical (hind paw volume - HPV), biochemical (activity of GGT in joint and level of TBARS in plasma), and immunological (IL-1 in plasma) parameters were assessed. Our results achieved with different antioxidants in monotherapies showed a reduction of oxidative stress in adjuvant arthritis independently of the chemical structure of the compounds. Pin was the most effective antioxidant tested in decreasing HPV. All combinations tested showed a higher efficacy in affecting biochemical or immunological parameters than Mtx administered in monotherapy. The findings showed the benefit of antioxidant compounds for their use in combination therapy with methotrexate.

Keywords: arthritis; methotrexate; combination therapy; oxidative stress; carnosine; coenzyme Q10; pyridoindoles; stilbenoids

  • Alarcón GS, Tracy IC, Blackburn WD Jr. (1989). Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 32(6): 671-6.CrossrefPubMedGoogle Scholar

  • Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D, Muhtaroglu S. (2005). Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38: 951-965.PubMedGoogle Scholar

  • Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M. (2006). Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 24: 307-311.PubMedCrossrefGoogle Scholar

  • Bauerova K, Nosalova V, Mihalova D, Navarova J. (2004). Contribution to safe anti-inflammatory therapy with indomethacin. Cent Eur J Public Health 12: S8-S10.PubMedGoogle Scholar

  • Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. (2005a). Effect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis. Biomed Pap 149(2): 501-503.CrossrefGoogle Scholar

  • Bauerova K, Valentova J, Poništ S, Navarova J, Komendova D, Mihalova D. (2005b). Effect of copper complexes on the development of adjuvant arthritis: Therapeutic and toxicological aspects. Biologia 60(17): 65-68.Google Scholar

  • Bauerova K, Poništ S, Ondrejíčkova O, Komendova D, Mihalova D. (2006). Association between tissue gamma glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuroendocrinol Lett 27: 172-175.Google Scholar

  • Bauerova K, Poništ S, Navarova J, Dubničkova M, Paulovičova E, Pajtinka M, Kogan G, Mihalova D. (2008a). Glucomannan in prevention of oxidative stress and inflammation occurring in adjuvant arthritis. Neuroendocrinology Lett 29(5): 691-696.Google Scholar

  • Bauerova K, Kucharska J, Poništ S, Gvozdjakova A. (2008b). In Mitochondrial medicine: mitochodrial metabolism, diseases, diagnosis and therapy. Gvozdjakova, eds, pp 340-342. Springer, NetherlandsGoogle Scholar

  • Bauerova K, Paulovičova E, Mihalova D, Švík K, Poništ S. (2009). Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukán® in adjuvant arthritis. Toxicology and Industrial Health 25(4-5): 329-335.PubMedWeb of ScienceCrossrefGoogle Scholar

  • Bauerova K, Paulovičova E, Mihalova D, Dráfi F, Štrosova M, Mascia C, Biasi F, Rovensky J, Kucharska J, Gvozdjakova A, Poništ S. (2010). Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress. Acta Biochimica Polonica 57(3): 347-354.PubMedGoogle Scholar

  • Boldyrev A. (2005). Protection of proteins from oxidative stress A new illusion or a novel strategy? Ann N Y Acad Sci 1057: 193-205.Google Scholar

  • Brown RK, Kelly FJ. (1996). Peroxides and other products. In: Free Radicals, a practical approach. Punchard NA, Kelly FJ, eds, pp 119-131. Oxford University Press, Oxford.Google Scholar

  • Cuzzocrea S, Mazzon E, di Paola R, Genovese T, Muià C, Caputi AP, Salvemini D. (2005). Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum 52(12): 3755-60.CrossrefPubMedGoogle Scholar

  • Dinarello CA, Moldawer LL. (2002). In Pro-inflammatory and anti-inflammatory cytokines in rheumatoid arthritis: a primer for clinicians. 3rd ed., pp 351, Thousand Oaks, CA: Amgen.Google Scholar

  • Drábikova K, Perečko T, Nosáľ R, Bauerova K, Poništ S, Mihalova D, Kogan G, Jančinova V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacological Research 59(6): 399-403.CrossrefWeb of ScienceGoogle Scholar

  • Dráfi F, Bauerova K, Valachova K, Poništ S, Mihalova D, Juránek I, Boldyrev A, Hrabárova E, Šoltés L. (2010). Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo. Neuroendocrinol Lett 31(2): 96-100.Google Scholar

  • Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. (2000). Mechanisms of action of methotrexate. Immunopharmacology 47: 247-257.PubMedCrossrefGoogle Scholar

  • Gvozdjakova A, Kucharska J, Tanaka S, Neradova B, Bauerova K. (2004). Coenzyme Q10 supplementation differently modulated heart and skeletal muscle mitochondrial function induced by adjuvant arthritis. Mitochondrion 4: 20-21.Google Scholar

  • He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, Chan AS, Lu AP. (2006). Anti-inflammatory and anti-oxidative effects of cherries on Freund's adjuvantinduced arthritis in rats. Scand J Rheumatol 35: 356-358.CrossrefGoogle Scholar

  • Jančinova V, Perečko T, Nosáľ R, Košťálova D, Bauerova K, Drábikova K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol 612(1-3): 161-6.Web of ScienceGoogle Scholar

  • Jančinova V, Nosáľ R, Lojek A, Číz M, Ambrozova G, Mihalova D, Bauerova K, Harmatha J, Perečko T. (2010). Formation of reactive oxygen and nitrogen species in the presence of pinosylvin - an analogue of resveratrol. Neuroendocrinol Lett. 31(2): 79-83.Google Scholar

  • Kogan G, Staško A, Bauerova K, Polovka M, Šoltés L, Brezova V, Navarova J, Mihalova D. (2005). Antioxidant properties of yeast (1→3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in adjuvant arthritis. Carbohydr Polym 61: 18-28.Google Scholar

  • Kogure T, Tatsumi T, Sato H, Oku Y, Kishi D, Ito T. (2010). Traditional herbal medicines (Kampo) for patients with rheumatoid arthritis receiving concomitant methotrexate: a preliminary study. Altern Ther Health Med 16: 46-51.PubMedGoogle Scholar

  • Mačičkova T, Drábikova K, Nosáľ R, Bauerova K, Mihalova D, Harmatha J, Pečivova J. (2010). In vivo effect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis. Neuroendocrinol Lett 31(2): 91-95.Google Scholar

  • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JM, Schaible TF, Feldmann M. (1998). Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41: 1552-1563.CrossrefPubMedGoogle Scholar

  • McKendry RJ, Dale P. (1993). Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 20(11): 1850-1856.PubMedGoogle Scholar

  • Moreland LW, Heck LW Jr, Koopman WJ. (1997). Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 40: 397-409.CrossrefPubMedGoogle Scholar

  • Ondrejičkova O, Ziegelhoeffer A, Gabauer I, Sotnikova R, Styk J, Gibala P, Sedlak J, Horákova L. (1993). Evaluation of ischemia-reperfusion injury by malondialdehyde, glutathione and gamma-glutamyl transpeptidase: lack of specific local effects in diverse parts of the dog heart following acute coronary occlusion. Cardioscience 4: 225-230.PubMedGoogle Scholar

  • Orlowski M, Meister A. (1970). The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci 67: 1248-1255.CrossrefGoogle Scholar

  • Perečko T, Jančinova V, Drábikova K, Nosáľ R, Harmatha J. (2008). Structureefficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosilvin and pterostilbene. Neuroendocrinol Lett 29: 802-805.Google Scholar

  • Poništ S, Mihalova D, Jančinova V, Šnirc V, Ondrejičkova O, Mascia C, Poli G, Stančikova M, Nosáľ R, Bauerova K. (2010). Reduction of oxidative stress in adjuvant arthritis. Comparison of efficacy of two pyridoindoles: stobadine dipalmitate and SMe1.2HCl. Acta Biochim Pol 57(2): 223-8.Google Scholar

  • Poništ S, Kucharska J, Gvozdjakova A, Komendova D, Mihalova D, Bauerova K. (2007). Mitochondrial bioenergetics of skeletal muscle studied in adjuvant arthritis. Chem Listy 101: 256-257.Google Scholar

  • Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D. (2010). Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4): 631-7.CrossrefPubMedGoogle Scholar

  • Sotnikova R, Poništ S, Navarova J, Mihalova D, Tomekova V, Štrosova M, Bauerova K. (2009). Effects of sesame oil in the model of adjuvant arthritis. Neuroendocrinol Lett 30: 22-24.Google Scholar

  • Rovensky J, Švík K, Stančikova M, Istok R, Ebringer L, Ferenčik M. (2002). Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium. Folia Microbiol 47: 573-578.CrossrefGoogle Scholar

  • Rovensky J, Švík K, Rovenska E, Štvrtinova V, Stančikova M. (2008). Effects of purified micronized flavonoid fraction (Detralex) on prophylactic treatment of adjuvant arthritis with methotrexate in rats. Isr Med Assoc J 10: 377-380.PubMedGoogle Scholar

  • Rovensky J, Stančikova M, Švík K, Bauerova K, Jurčovičova J. (2009a). The effects of beta-glucan isolated from Pleurotus ostreatus on methotrexate treatment in rats with adjuvant arthritis. Rheumatol Int doi: 10.1007/s00296-009-1258-zGoogle Scholar

  • Rovensky J, Stančikova M, Rovenska E, Štvrtina S, Štvrtinova V, Švík K. (2009b). Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination. Ann N Y Acad Sci 1173: 798-804.Google Scholar

  • Sarban A, Kocyigit A, Yazar M, Isikan UE. (2005). Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38: 981-986.CrossrefPubMedGoogle Scholar

  • Štolc S, Bauer V, Benes L, Tichy M. (1983). Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: CS 229 067, SWED. 8204693-9, BELG. 894148, SWISS 651 754, BRD P-3231088, SPAIN 553 017, JAP. 151 4040.Google Scholar

  • Štrosova M, Tomaškova I, Poništ S, Bauerova K, Karlovska J, Spickett CM, Horákova L. (2008). Oxidative impairment of plasma and skeletal muscle sarcoplasmic reticulum in rats with adjuvant arthritis - effects of pyridoindole antioxidants. Neuroendocrinol Lett 29: 706-711.Google Scholar

  • Štrosova M, Karlovska J, Spickett CM, Országhova Z, Poništ S, Bauerova K, Mihalova D, Horákova L. (2009). Modulation of SERCA in the chronic phase of adjuvant arthritis as a possible adaptation mechanism of redox imbalance. Free Radic Res 43: 852-864.Web of ScienceGoogle Scholar

  • Tastekin N, Aydogdu N, Dokmeci D, Usta U, Birtane M, Erbas H, Ture M. (2007). Protective effects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res 56: 303-310.CrossrefPubMedGoogle Scholar

  • Weinblatt ME. (2003). Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 62(2): 94-6.Google Scholar

  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. (1999). A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253-259.CrossrefPubMedGoogle Scholar

  • Williams HJ, Willkens RF, Samuelson CO Jr, Alarcon GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR. (1985). Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721-730.CrossrefGoogle Scholar

About the article

Published Online: 2011-04-18

Published in Print: 2011-03-01

Citation Information: Interdisciplinary Toxicology, ISSN (Online) 1337-9569, ISSN (Print) 1337-6853, DOI: https://doi.org/10.2478/v10102-011-0007-9.

Export Citation

This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Viera Jančinová, Silvia Pažoureková, Marianna Lucová, Tomáš Perečko, Danica Mihalová, Katarína Bauerová, Radomír Nosáľ, and Katarína Drábiková
International Immunopharmacology, 2015, Volume 28, Number 1, Page 175
K. Bauerova, S. Ponist, V. Kuncirova, D. Mihalova, E. Paulovicova, and N. Volpi
Osteoarthritis and Cartilage, 2011, Volume 19, Number 11, Page 1373
Qiu-Yi Choo, Samuel Chao Ming Yeo, Paul C. Ho, Yoshiya Tanaka, and Hai-Shu Lin
Journal of Functional Foods, 2014, Volume 11, Page 352
Katarina Bauerova, Alessandra Acquaviva, Silvester Ponist, Concetta Gardi, Daniela Vecchio, Frantisek Drafi, Beatrice Arezzini, Lydia Bezakova, Viera Kuncirova, Danica Mihalova, and Radomir Nosal
Autoimmunity, 2015, Volume 48, Number 1, Page 46
Manish Kumar Jeengar, Shweta Shrivastava, Kala Nair, Sreenivasa Reddy Singareddy, Uday Kumar Putcha, M. V. N. Kumar Talluri, V. G. M. Naidu, and Ramakrishna Sistla
Inflammation, 2014, Volume 37, Number 6, Page 2139
Saqlain Haider, Mohammad Sarwar Alam, Hinna Hamid, Syed Shafi, Abhijeet Dhulap, Firasat Hussain, Perwez Alam, Sadiq Umar, M.A.Q. Pasha, Sameena Bano, Syed Nazreen, Yakub Ali, and Chetna Kharbanda
European Journal of Medicinal Chemistry, 2014, Volume 81, Page 204
Enma Conde, Wenwen Fang, Jarl Hemming, Stefan Willför, Herminia Domínguez, and Juan Carlos Parajó
Wood Science and Technology, 2014, Volume 48, Number 2, Page 311
Peijian Tong, Chengliang Wu, Xiaofen Wang, Hongzhou Hu, Hongting Jin, Changyu Li, Ying Zhu, Letian Shan, and Luwei Xiao
Journal of Ethnopharmacology, 2013, Volume 146, Number 2, Page 562
Viera Jančinová, Tomáš Perečko, Rado Nosáľ, Juraj Harmatha, Jan šmidrkal, and Katarína Drábiková
Acta Pharmacologica Sinica, 2012, Volume 33, Number 10, Page 1285
Sadiq Umar, Anubhav Kumar, Mir Sajad, Jamil Zargan, Md. Meraj Ansari, Sayeed Ahmad, Chandra Kant Katiyar, and Haider A. Khan
Rheumatology International, 2013, Volume 33, Number 3, Page 657
Souvik Roy, Santanu Sannigrahi, Ram Prasad Vaddepalli, Balaram Ghosh, and Priyanka Pusp
Inflammation, 2012, Volume 35, Number 4, Page 1435
Sadiq Umar, Jamil Zargan, Khalid Umar, Sayeed Ahmad, Chandra Kant Katiyar, and Haider A. Khan
Chemico-Biological Interactions, 2012, Volume 197, Number 1, Page 40

Comments (0)

Please log in or register to comment.
Log in